Impact of Obesity on Complication Rates, Clinical Outcomes, and Quality of Life after Minimally Invasive Transforaminal Lumbar Interbody Fusion.


Journal

Journal of neurological surgery. Part A, Central European neurosurgery
ISSN: 2193-6323
Titre abrégé: J Neurol Surg A Cent Eur Neurosurg
Pays: Germany
ID NLM: 101580767

Informations de publication

Date de publication:
Mar 2021
Historique:
pubmed: 23 12 2020
medline: 22 6 2021
entrez: 22 12 2020
Statut: ppublish

Résumé

 Percutaneous pedicle screw fixation in obese patients remains a surgical challenge. We aimed to compare patient-reported outcomes and complication rates between obese and nonobese patients who were treated by minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF).  The authors retrospectively reviewed patients who underwent MIS-TLIF at a single institution between 2011 and 2014. Patients were classified as obese (body mass index [BMI] ≥30 kg/m  The final study group consisted of 71 patients, 24 obese (33.8%, 34.8 ± 3.8 kg/m  Obese patients can achieve similar improvement of the pain intensity and functional status even at long-term follow-up. In patients with appropriate surgical indications, obesity should not be considered a contraindication for MIS-TLIF surgery.

Sections du résumé

BACKGROUND BACKGROUND
 Percutaneous pedicle screw fixation in obese patients remains a surgical challenge. We aimed to compare patient-reported outcomes and complication rates between obese and nonobese patients who were treated by minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF).
METHODS METHODS
 The authors retrospectively reviewed patients who underwent MIS-TLIF at a single institution between 2011 and 2014. Patients were classified as obese (body mass index [BMI] ≥30 kg/m
RESULTS RESULTS
 The final study group consisted of 71 patients, 24 obese (33.8%, 34.8 ± 3.8 kg/m
CONCLUSION CONCLUSIONS
 Obese patients can achieve similar improvement of the pain intensity and functional status even at long-term follow-up. In patients with appropriate surgical indications, obesity should not be considered a contraindication for MIS-TLIF surgery.

Identifiants

pubmed: 33352610
doi: 10.1055/s-0040-1718758
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-153

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Lukas Goertz (L)

Center for Neurosurgery, University Hospital Cologne, Cologne, Nordrhein-Westfalen, Germany.

Pantelis Stavrinou (P)

Center for Neurosurgery, University Hospital Cologne, Cologne, Nordrhein-Westfalen, Germany.

Christina Hamisch (C)

Center for Neurosurgery, University Hospital Cologne, Cologne, Nordrhein-Westfalen, Germany.

Moritz Perrech (M)

Center for Neurosurgery, University Hospital Cologne, Cologne, Nordrhein-Westfalen, Germany.

Dierk-Marko Czybulka (DM)

Center for Neurosurgery, University Hospital Cologne, Cologne, Nordrhein-Westfalen, Germany.

Kaveh Mehdiani (K)

Center for Neurosurgery, University Hospital Cologne, Cologne, Nordrhein-Westfalen, Germany.

Marco Timmer (M)

Center for Neurosurgery, University Hospital Cologne, Cologne, Nordrhein-Westfalen, Germany.

Roland Goldbrunner (R)

Center for Neurosurgery, University Hospital Cologne, Cologne, Nordrhein-Westfalen, Germany.

Boris Krischek (B)

Center for Neurosurgery, University Hospital Cologne, Cologne, Nordrhein-Westfalen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH